• SENSEX 76,617.44
    592.93 (+0.78%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Kalyan Jewellers
    519.15 794.60(%)
  • Dr Lal Pathlabs
    2,508.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    212.60 304.50(%)
  • SRF
    2,986.25 3,074.95(%)
  • Bengal & Assam
    7,450.00 11,498.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,610.00 2,929.98(%)
  • Suzlon Energy
    57.74 86.04(%)
  • SpiceJet
    46.10 79.90(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Adani Green
    944.95 2,173.65(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,660.50 3,276.30(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Titan Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4349.0
  • ISIN : INE150C01011
454.45 33 (7.80%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    420.15

  • Today’s High

    461.00

  • Open

    420.15

  • Perv Close

    421.55

  • 52W Low

    412.00

  • 52W High

    1,017.85

Key Indicators

  • P/E(TTM)

    19.41

  • Mar.Cap (₹Cr.)

    375.54

  • Div & Yield %

    0.44

  • Book Value(₹)

    166.49

  • Debt-Equity Ratio

    7.80

  • AGM Date

    01-Apr-2025

  • EPS

    23.41

  • P/E Ratio

    19.41

Financials Ratios

  • Debt-Equity Ratio

    0.07

  • Mar.Cap (₹Cr.)

    375.54

  • RONW (%)

    19.44

  • ROCE (%)

    24.84

Score Board

  • Equity (₹ in Cr.)

    8.26

  • BV (₹)

    166.50

  • Sales( ₹ in Cr.)

    164.07

  • NP (in Cr.)

    23.66

  • NP Var(%)

    13.0

  • Div%

    20.0

  • CPS (₹)

    32.70

  • EPS (₹)

    28.60

  • Traded Value (₹ in Lakhs)

    375.54

  • 52 Week High

    1,017.85

  • 52 Week Low

    412.00

  • Price BSE

    454.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    375.54

  • P/C Ratio

    13.90

  • P/E Ratio

    15.90

  • Price Vs.BV

    28.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 164.07 144.00 123.55 122.46 69.48 58.24
Excise Duty 164.07 144.00 123.55 122.46 69.48 58.24
Net Sales 164.07 144.00 123.55 122.46 69.48 58.24
Other Income 1.75 1.94 0.94 0.66 0.41 0.65
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 165.82 145.94 124.49 123.12 69.89 58.89
EXPENDITURE :
Raw Materials 164.07 144.00 123.55 122.46 69.48 58.24
Power & Fuel Cost 164.07 144.00 123.55 122.46 69.48 58.24
Employee Cost 23.71 18.21 14.24 12.04 10.03 8.49
Other Manufacturing Expenses 0.95 0.96 0.52 0.69 0.16 0.55
Selling & Administrative Expenses 11.25 9.56 6.93 4.94 7.75 7.54
Miscellaneous Expenses 0.95 0.96 0.52 0.69 0.16 0.55
Less : Pre-operative Expenses Capitalised :
Total Expenditure 134.29 117.83 95.52 84.03 62.26 54.54
Operating Profit 18.27 15.87 11.64 9.67 4.58 3.63
Interest 1.17 0.75 0.87 1.28 1.90 2.04
Gross Profit 31.53 28.12 28.97 38.76 8.24 4.36
Depreciation 3.33 2.60 2.37 2.10 1.75 1.68
Profit Before Tax 31.53 28.12 28.97 38.76 8.24 4.36
Tax 7.79 7.21 7.35 9.85 1.85 1.03
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.11 -0.09 -0.07 0.13 0.19 0.25
Reported Net Profit 23.66 21.02 21.68 28.77 6.20 3.08
Extraordinary Items 31.53 28.12 28.97 38.76 8.24 4.36
Adjusted Net Profit 23.66 21.02 21.68 28.77 6.20 3.08
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 1.65 1.49 1.24 1.24 0.83 0.00
P & L Balance carried down 23.66 21.02 21.68 28.77 6.20 3.08
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 20.00 18.00 15.00 15.00 10.00 0.00
Dividend Per Share(Rs) 2.00 1.80 1.50 1.50 1.00 0.00
Earnings Per Share-Unit Curr 28.64 25.44 26.24 34.82 7.50 3.73
Book Value 1.65 1.49 1.24 1.24 0.83 0.00
Book Value(Adj)-Unit Curr 1.65 1.49 1.24 1.24 0.83 0.00

Shareholding Pattern

  • Promoter Group

    55.88%

  • Public Share Holding

    44.12%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,120,610 49.86 4,120,610 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 496,905 6.01 496,905 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,617,515 55.88 4,617,515 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 141,949 1.72 137,949 41
Clearing Members 50 0.00 50 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 226,513 2.74 226,513 326
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 77,238 0.93 77,238 160
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 302,232 3.66 302,232 6
Individuals holding nominal share capital up to Rs. 1 lakh 2,129,720 25.77 1,876,909 15,488
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 767,983 9.29 767,983 1
Sub Total 3,646,185 44.12 3,389,374 16,024
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,263,700 100.00 8,006,889 16,038

Company Background

Titan Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Titan Biotech Ltd
  • BSE Code : 4349.0
  • ISIN : INE150C01011

  • Incorporation Year

    1992

  • Registered Office

    A-902 A RIICO Industrial Area
    Phase III Alwar District, Bhiwadi,
    Rajasthan-301019

  • Telephone

    91-011-27355742/27674615

  • FAX

    91-011-47619811

  • Chairman

    Rohit Jain

  • Managing Director

    Naresh Kumar Singla

  • Company Secretary

    Charanjit Singh

  • Auditor

    A N S K & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99 ,
    Madangir Behind LSC ,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Titan Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Titan Biotech 454.45 165.82 164.07 19.41 25.70
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92